Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel N Cohen

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 9, 2008
Crystal and cryoEM structural studies of a cell wall degrading enzyme in the bacteriophage phi29 tailYe Xiang, Marc C Morais, Daniel N Cohen, et al.
International Journal of Clinical and Experimental Pathology|October 23, 2014
The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorderMegan C Smith, Daniel N Cohen, Bruce Greig, et al.
Open Forum Infectious Diseases|November 19, 2020
Corrigendum to: Normal Respiratory Flora as a Cause of Community-Acquired PneumoniaDaniel M Musher, Sirus J Jesudasen, Joseph W Barwatt, et al.
Open Forum Infectious Diseases|September 24, 2020
Normal Respiratory Flora as a Cause of Community-Acquired PneumoniaDaniel M Musher, Sirus S Jesudasen, Joseph W Barwatt, et al.
Journal of Molecular Biology|April 14, 2009
Shared catalysis in virus entry and bacterial cell wall depolymerizationDaniel N Cohen, Yuk Y Sham, Greg D Haugstad, et al.
Ejhaem|July 18, 2022
The contribution of human papilloma virus infection to cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemiaPreeya Bhavsar-Bhakta, Mugahed Hamza, Sepideh Mehravaran, et al.
Cancer Immunology Research|February 4, 2014
Severe cutaneous and neurologic toxicity in melanoma patients during vemurafenib administration following anti-PD-1 therapyDouglas B Johnson, Erika K Wallender, Daniel N Cohen, et al.
Future Oncology (London, England)|January 6, 2026
A Phase III study of perioperative dostarlimab in patients with dMMR/MSI-H resectable colon cancer: AZUR-2 study designNaureen Starling, Elena Elez, John H Strickler, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 15, 2022
Association of artificial intelligence-powered and manual quantification of programmed death-ligand 1 (PD-L1) expression with outcomes in patients treated with nivolumab ± ipilimumabVipul Baxi, George Lee, Chunzhe Duan, et al.
NPJ Precision Oncology|February 23, 2019
Genomic landscape of a metastatic malignant proliferating tricholemmal tumor and its response to PI3K inhibitionJean-Nicolas Gallant, Andrew Sewell, Karinna Almodovar, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|July 9, 2008
Crystal and cryoEM structural studies of a cell wall degrading enzyme in the bacteriophage phi29 tailYe Xiang, Marc C Morais, Daniel N Cohen, et al.
International Journal of Clinical and Experimental Pathology|October 23, 2014
The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorderMegan C Smith, Daniel N Cohen, Bruce Greig, et al.
Open Forum Infectious Diseases|November 19, 2020
Corrigendum to: Normal Respiratory Flora as a Cause of Community-Acquired PneumoniaDaniel M Musher, Sirus J Jesudasen, Joseph W Barwatt, et al.
Open Forum Infectious Diseases|September 24, 2020
Normal Respiratory Flora as a Cause of Community-Acquired PneumoniaDaniel M Musher, Sirus S Jesudasen, Joseph W Barwatt, et al.
Journal of Molecular Biology|April 14, 2009
Shared catalysis in virus entry and bacterial cell wall depolymerizationDaniel N Cohen, Yuk Y Sham, Greg D Haugstad, et al.
Ejhaem|July 18, 2022
The contribution of human papilloma virus infection to cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemiaPreeya Bhavsar-Bhakta, Mugahed Hamza, Sepideh Mehravaran, et al.
Cancer Immunology Research|February 4, 2014
Severe cutaneous and neurologic toxicity in melanoma patients during vemurafenib administration following anti-PD-1 therapyDouglas B Johnson, Erika K Wallender, Daniel N Cohen, et al.
Future Oncology (London, England)|January 6, 2026
A Phase III study of perioperative dostarlimab in patients with dMMR/MSI-H resectable colon cancer: AZUR-2 study designNaureen Starling, Elena Elez, John H Strickler, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 15, 2022
Association of artificial intelligence-powered and manual quantification of programmed death-ligand 1 (PD-L1) expression with outcomes in patients treated with nivolumab ± ipilimumabVipul Baxi, George Lee, Chunzhe Duan, et al.
NPJ Precision Oncology|February 23, 2019
Genomic landscape of a metastatic malignant proliferating tricholemmal tumor and its response to PI3K inhibitionJean-Nicolas Gallant, Andrew Sewell, Karinna Almodovar, et al.
Pageof 3